miRNA-34a underexpressed in Merkel cell polyomavirus-negative Merkel cell carcinoma. 2015

Tuukka Veija, and Helka Sahi, and Virve Koljonen, and Tom Bohling, and Sakari Knuutila, and Neda Mosakhani
Department of Pathology, University of Helsinki and HUSLAB, P.O. Box 21, 00014, Helsinki, Finland, tuukka.veija@helsinki.fi.

Merkel cell polyomavirus (MCV) is frequently detectable in Merkel cell carcinoma (MCC) tumors, but the significance of MCV infection is not yet totally understood. Thus far, no key regulatory miRNA has been identified for MCC tumorigenesis. However, distinct miRNA expression profiles have been suggested for MCV-positive and MCV-negative tumors. We used microarray hybridization to identify miRNA expression differences in MCC tumor samples according to MCV status and further validated these results by quantitative reverse transcription polymerase chain reaction (qRT-PCR). When compared with MCV-negative tumors, we detected overexpression of miR-34a, miR-30a, miR-142-3p, and miR-1539 in those MCV positives. In addition, slight underexpression was detectable in MCV-positive tumors of miR-181d. We confirmed the distinct expression of miRNAs in MCV-positive and MCV-negative tumors and confirmed statistically significant underexpression of miR-34a in MCV-negative tumors by both array analysis and qRT-PCR. Neither tumor location nor development of metastases affected miRNA expression.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face

Related Publications

Tuukka Veija, and Helka Sahi, and Virve Koljonen, and Tom Bohling, and Sakari Knuutila, and Neda Mosakhani
August 2019, The Journal of dermatology,
Tuukka Veija, and Helka Sahi, and Virve Koljonen, and Tom Bohling, and Sakari Knuutila, and Neda Mosakhani
June 2009, Uirusu,
Tuukka Veija, and Helka Sahi, and Virve Koljonen, and Tom Bohling, and Sakari Knuutila, and Neda Mosakhani
July 2020, Cancers,
Tuukka Veija, and Helka Sahi, and Virve Koljonen, and Tom Bohling, and Sakari Knuutila, and Neda Mosakhani
October 2017, Philosophical transactions of the Royal Society of London. Series B, Biological sciences,
Tuukka Veija, and Helka Sahi, and Virve Koljonen, and Tom Bohling, and Sakari Knuutila, and Neda Mosakhani
November 2019, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
Tuukka Veija, and Helka Sahi, and Virve Koljonen, and Tom Bohling, and Sakari Knuutila, and Neda Mosakhani
April 2015, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
Tuukka Veija, and Helka Sahi, and Virve Koljonen, and Tom Bohling, and Sakari Knuutila, and Neda Mosakhani
January 2021, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,
Tuukka Veija, and Helka Sahi, and Virve Koljonen, and Tom Bohling, and Sakari Knuutila, and Neda Mosakhani
December 2016, Future science OA,
Tuukka Veija, and Helka Sahi, and Virve Koljonen, and Tom Bohling, and Sakari Knuutila, and Neda Mosakhani
September 2008, Emerging infectious diseases,
Tuukka Veija, and Helka Sahi, and Virve Koljonen, and Tom Bohling, and Sakari Knuutila, and Neda Mosakhani
October 2016, Current opinion in virology,
Copied contents to your clipboard!